COVID-19: Current and Future Impacts

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course reviews the latest research developments on the current an future impacts of COVID-19 and potential solutions.
The COVID-19 era has given rise to a series of major life stressors, including illness and death caused by a global pandemic, stay-at-home orders, disruptions in employment and income, food and supply shortages, as well as housing instability. As a result of these factors, epidemiological evidence suggests that the pandemic has increased alcohol use, opioid use, and the prevalence of certain psychological disorders. Furthermore, minoritized persons with substance use disorders are a particularly vulnerable population because of their unique social and health care needs, which place them at risk for significant harm from both the pandemic itself and its social and economic consequences. This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course explores the impacts of the COVID-19 pandemic as well as potential solutions. Following each presentation, presenters answer audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Emerging Trends in Alcohol Misuse and Related Harms During and After the Pandemic
  Epidemiological evidence suggests a mixed picture for alcohol use during the COVID-19 pandemic.  Overall, there was a trend towards increased alcohol consumption, with some groups, including women, showing greater increases than others.  After increasing around 2.2% per year over the previous two decades, deaths involving alcohol jumped 25.5% between 2019 to 2020.  Mental health factors were the most common correlates or triggers for increased use of alcohol.  There is a need for increased vigilance for alcohol-related problems and there is likely to be an increase in the need for alcohol treatment.  Problematic alcohol use which is not addressed can lead to adverse consequences for individuals and families, and has significant costs for health systems.
• Opioid Use Disorder Treatment without Red Tape? What We Learned During COVID-19
  Access to medications for opioid use disorder (MOUD), including methadone and buprenorphine, are substantially restricted by controlled substance regulations that present a burden to many patients. For example, methadone patients are typically required to travel to opioid treatment programs daily to receive observed doses of medication and buprenorphine patients have not historically been allowed to start medication based on a telephone or video consult. However, many regulations were suspended or modified after the COVID-19 public health emergency. This "natural experiment" has taught the field important lessons about possible new directions for increasing access, such as take home methadone and telehealth for buprenorphine, in a less burdensome manner. This talk will review the evidence in support of the argument for making the COVID-19 regulations permanent.
• Racism, COVID-19, and Racial/Ethnic Behavioral Health Inequities
  Racial and ethnic minorities have shouldered a disproportionate medical, emotional and social burden of the COVID-19 pandemic. This presentation will discuss racial and ethnic disparities in COVID-19 infection and associated consequences. The presentation will highlight the contribution of structural racism on disparities in social determinants of health that place Black, Latinx and Other People of Color at increased risk for Covid-19 infection, morbidity and mortality. It will also explore the intersectionality of race and substance use disorder on COVID-related outcomes for minoritized populations, especially Black persons in the United States.
• Symptoms of Psychological Distress Among U.S. Adults over the Course of the COVID-19 Pandemic
  This presentation will describe a longitudinal survey of a nationally representative cohort of U.S. adults measuring psychological distress in April 2020, July 2020, November 2020, and July 2021. Study results include measures of psychological distress, using the validated Kessler-6 measure, at each time point, as well as measures of treatment seeking and receipt. Discussion will focus on the trajectory of psychological distress over the course of the COVID-19 pandemic among U.S. adults overall and among specific demographic sub-groups. The presentation will conclude with consideration of the implications of study results for public mental health moving forward.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Co-Occurring Psychiatric Disorders

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course explores new research in preventing, screening, and treating psychiatric disorders among people with substance use disorders. Topics include suicide, methamphetamine psychosis, ADHD, depression, and anxiety.
There is a high prevalence of psychiatric comorbidity among people with substance use disorders, with some studies showing as high as 80% having another mental health condition. This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course explores new research in preventing, screening, and treating psychiatric disorders among people with substance use disorders. Topics include suicide, methamphetamine psychosis, ADHD, depression, and anxiety. Following the session, a moderated panel discussion among the presenters answers audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Addiction, Overdose, Suicide & the Gray Areas in Between
  About 50,000 people die each year in the USA from Suicide and another 70,000 die from Overdoses, ( 50,000 from opioids). This presentation with review data and interactions about Suicide and Overdose, including clinical presentations and possible interventions which may affect either or both problems. Clinical screening methods for suicide have been developed and tested over many years and include both clinical and demographic issues. The role of substance use disorders has not previously been fully appreciated as a major risk factor, nor intervention in substance use disorders fully appreciated as a possible suicide intervention.
• Over-amped: Managing Methamphetamine Use Disorder and Methamphetamine Psychosis
  Methamphetamine is among the common substances of abuse related to emergency service utilization; psychosis due to methamphetamine use may be mistaken for primary psychiatric illness but in fact requires quite different treatment. Early recognition and appropriate intervention is critical. This talk reviews the epidemiology of methamphetamine use in emergency settings and describes original data of a novel intervention for treating methamphetamine-induced psychosis. A structured, emergency department-initiated intervention illustrates core elements of engaging patients presenting with methamphetamine psychosis.
• Treatment of ADHD and Substance Use Disorders
  Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders (SUD) are highly comorbid, with 15-20% of treatment-seekers for SUD having current ADHD. Individuals with SUD and ADHD are more likely to relapse and less likely to be retained in treatment than those without ADHD. To date, treatment trials targeting individuals with ADHD and SUD have produced mixed results. Data from 2 studies found that among adults with ADHD and stimulant use disorder, robust dosing produced clinically meaningful therapeutic effects on the ADHD symptoms and illicit stimulant use. However, prescribing prescription stimulants needs to be done carefully to mitigate the risks of nonmedical use and diversion. Pillars of safe prescribing include accurate diagnosis, clear and defined target outcomes and careful monitoring for misuse.
• Depression and Anxiety in Patients with Addiction
  Co-occurring mood and anxiety disorders are highly prevalent among patients with substance use disorders, and if left untreated, they usually have a negative impact on addiction recovery. This session will review pharmacologic treatments for mood and anxiety disorders in the context of different substance use disorders (SUD). Principles of assessment and diagnosis will be presented since it is frequently unclear as to the source of mood and anxiety symptoms in the context of SUD that may be substance-induced and may or may not reach disorder-level severity or threshold. Then, when appropriate, stepped treatment strategies will be discussed.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Co-Occurring Medical Disorders

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring medical disorders, such as HCV, Drug Use-Associated Infective Endocarditis (DUA-IE), liver disease, and Skin and Soft Tissue Infections (SSTIs).
Patients receiving addiction treatment frequently present with medical and psychological conditions that can greatly affect their overall well-being. This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring medical disorders, such as HCV, Drug Use-Associated Infective Endocarditis (DUA-IE), liver disease, and Skin and Soft Tissue Infections (SSTIs). Following each presentation, presenters answer audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Removing "Alcoholic" from Alcohol Related Liver Disease
  Alcohol related liver disease and its consequences are on the rise. Identification of unhealthy alcohol use along with the provision of evidenced-based treatment can improve overall liver health. In this session, we will discuss alcohol related liver disease, its management, including the use of early liver transplant, and the importance of integrating care for alcohol use concurrently with treatment for liver disease. We will also discuss the importance of identifying and reducing stigma associated with alcohol related liver disease.
• Shifting the Treatment Paradigm for Endocarditis Among People Who Use Drugs: Treat the Person, Not Just the Infection
  Drug use-associated IE (DUA-IE) now accounts for 1 in 10 hospitalizations endocarditis with an inpatient mortality rate between 5-8% and up to 26% in the year following discharge. At this rate, nearly 300,000 Americans will die of DUE-IE between 2020 and 2030. There is an urgent need to address the growing burden of DUA-IE in the U.S. To do so, providers must shift the treatment paradigm from a "do as I say" approach to a patient-focused "what do you need?" approach. Individuals with DUA-IE require more than just intravenous antibiotics. In this session, we will explore treatment paradigms that treat the person, not just the infection, to improve clinical outcomes and quality of life.
• One Size Does Not Fit All: HCV Care in Various Settings
  Hepatitis C virus (HCV) infection is the leading cause of infectious disease death in the US. Despite the availability of effective oral direct acting agents (DAA) of short duration (2-3months) which have minimal side effects and cure HCV in over 95% of people who take these medications, treatment uptake among people who use drugs remains low. This session will review the current simplified approach to HCV screening and treatment as a prelude to a discussion of barriers to HCV treatment uptake among people who use drugs and strategies with proven effectiveness to increase HCV treatment uptake. These strategies will focus on integrated care, low threshold and peer supported approaches
• Meeting People Where They are: Integrating Wound Care with Addiction Services
  In this talk we will review the impact of and risk factors for skin and soft tissue infections (SSTIs) among people who inject drugs (PWID), as well as barriers to healthcare and benefits of integrating wound care into addiction services. We will describe a model of integrated street medicine services for people who use drugs located in Baltimore, and successes and challenges with providing wound care in this model. We will review basic clinical wound care for PWID, with a focus on outpatient care and counseling for patients in SSTI prevention and wound care.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

New Evidence for Non-Pharmacological Treatment

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course examines research on Cognitive Behavioral Therapy for Insomnia (CBT.i), Alcoholics Anonymous (AA) and clinician-facilitated AA (Twelve-Step Facilitation, TSF), the Common Elements Treatment Approach (CETA), and Contingency Management (CM). Presentations will provide essential information for clinicians working in non-specialty settings who may wish to utilize proven strategies.
In addition to pharmacological treatment, addiction providers should have a robust toolbelt of non-pharmacological treatment approaches. Presentations in This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course examines research on Cognitive Behavioral Therapy for Insomnia (CBT.i), Alcoholics Anonymous (AA) and clinician-facilitated AA (Twelve-Step Facilitation, TSF), the Common Elements Treatment Approach (CETA), and Contingency Management (CM). Presentations will provide essential information for clinicians working in non-specialty settings who have little knowledge of, or experience with these non-pharmacological approaches but who may wish to utilize proven strategies. Following the session, a moderated panel discussion among the presenters answers audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• The Role of Sleep Treatment in Addiction Medicine
  The average human adult will spend one-third of their life asleep. It is essential for human health. Yet 1 in 3 to 4 adults in the United States will experience insomnia at some point in their lives, and rates are even higher among those who drink alcohol. This session reviews multidimensional conceptualizations of sleep health, the prevalence of sleep disorders across the spectrum of Alcohol Use Disorder, and the feasibility and efficacy of insomnia treatment in reducing alcohol use outcomes.
• Twelve Step Facilitation: An Update
  Twelve Step Facilitation (TSF) is an evidence based treatment developed in the early 90's, which developed methods for clinicians to utilize to help patients to attend and benefit from attending 12 Step meetings ( specifically Alcoholics Anonymous (AA) - but can be used for other Anonymous programs). Just as a clinician might utilize Motivational Interviewing or CBT strategies within a session, A recent Cochrane review concluded that TSF was just as effective as these interventions, and in fact more effective in patients attaining abstinence from substances. There are over 60,000 AA groups a week in the USA. This presentation will demonstrate a few simple and brief methods for TSF which can be easily incorporated into clinicians sessions.
• The CETA System of Care: An Innovative Way to Improve Behavioral/Mental Health Care
  The Common Elements System of Care Approach (www.cetaglobal.org) is an innovative approach to solving some of the challenges within mental and behavioral health care, such as long wait lists, frequent referrals, long treatment time, and ineffective care. It incorporates evidence-based assessment and triage, a range of clinical services, and monitoring and evaluation. It is designed to address comorbidity (inclusive of substance use and interpersonal violence), a wide range of severities, and work across the lifespan. This presentation will present evidence for the effectiveness of the CETA system, as well as walk through why mental/behavioral health needs innovation and change to progress.
• Update on Contingency Management Research and Practice
  The rise of methamphetamine use across the US and the recent regulatory changes by the federal government have led to increased interest in contingency management. Further, research advances include increased evidence for contingency management as an intervention for alcohol use disorder, demonstrations that adapted versions of contingency management are effective for minorities groups, as well as initial research on the science of dissemination and implementation of the intervention in practice settings. This talk will provide an overview of contingency management, recent advancements in contingency management research, and federal policy changes that for the first time provide clear guidance on how contingency management can be used to treat substance use disorders with Medicaid and Medicare enrollees.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Addressing Treatment Disparities

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course outlines addiction related disparities and promising treatment approaches for four different populations, including rural and socioeconomically deprived, Latino, immigrant, and transgender populations.
There is an urgent need to address health disparities related to addiction among certain marginalized populations. These disparities are a result of individual, interpersonal, organizational, community and policy factors that both increase a population's risk of addiction as well as cause barriers for them to access addiction treatment. The presentations in this 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course outlines addiction related disparities and promising treatment approaches for four different populations, including rural and socioeconomically deprived, Latino, immigrant, and transgender populations. Following each presentation, presenters answer audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Urban/Rural/Racial Disparities in Access to Buprenorphine and Opioid Treatment Programs
  This presentation demonstrates disparities in access to opioid treatment programs and buprenorphine providers for the treatment of opioid use disorder and associations between access to treatment, deprivation, and rurality and treatment outcomes. Geospatial analyses were conducted at the level of block groups (600-3000 people), the smallest spatial unit for which the U.S. Census Bureau provides sociodemographic data. Compared to metropolitan block groups, access to treatment was lower in micropolitan, small town, rural, and more socioeconomically deprived areas. American Indian/Alaska Native majority block groups had lower access to treatment compared to white or other racial/ethnic majority block groups. Analysis of barriers to access is necessary to devising initiatives to enhance access to treatment for the treatment of opioid use disorders.
• Screening and Intervening on Structural Determinants of Health for Minoritized Individuals in Addiction Medicine 
  There is an urgent need for health disparities research to reduce the disproportionate burden of negative consequences related to alcohol use among socially disadvantaged Latinos compared to other racial/ethnic groups. Cultural adaptation of evidence-based treatments, such as motivational interviewing (MI), can improve access and overall response to alcohol treatment. However, research progress has been hindered by the few theoretically-guided tests of adaptation and limited knowledge about the active ingredients and mechanisms of behavior change that might discriminate an adapted, compared to non-adapted, intervention. This presentation will examine novel mechanisms of culturally adapted MI (CAMI), including decreases in perceived acculturation stress and reduced depression and anxiety, that may improve understanding of the stress-health behavior link observed among health disparities populations and how MI can be used to disrupt this association.  
• ¿Cómo se dice Affordable Care? Immigrant health, access to care, and COVID-19
  The health and human dignity of undocumented immigrants (and others with tenuous legal residency status) and their families are frequently challenged by immigration integration policies and enforcement activities. In the US, undocumented immigrants are systematically excluded from the health system. In this session, we will discuss immigrant status as a social determinant of health, and the impact of immigration policy on health equity and public health, with special focus on mental health, substance use, and the COVID-19 pandemic.
• Health Disparities among Transgender Women
  Transgender women in the US demonstrate numerous detrimental individual and structural health disparities, which impede their access to and engagement in HIV care and substance use services. These include disproportionate rates of individual-level health disparities such as lack of perceived support, cycles of incarceration, and untreated or undertreated substance use and mental health disorders, which are highly comorbid. Structural determinants of health include poverty and housing instability, lack of access to health insurance, transphobic stigma and discrimination, including transphobic stigma and discrimination specifically from healthcare providers. SUD is a demonstrated barrier to HIV care and behavioral health outcomes including poor linkage to care, ART nonadherence, increased high-cost emergency department visits, engagement in the street economy, and cycles of incarceration.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Stimulants and Synthetic Drugs

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course highlights the latest research and emerging topics on stimulants and synthetic drugs, including the stimulant and fentanyl overdose mortality epidemic, synthetic stimulants and opioids, psychophysiological phenotyping of reward processing, and promising treatment approaches for Methamphetamine Use Disorder.
According to the CDC, from 2012 through 2020 in the United States, the number of deaths involving methamphetamine increased more than 6-fold while the number of deaths involving cocaine more than tripled. These numbers have continued to rise since the beginning of the COVID-19 pandemic. Presentations in This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course highlights the latest research and emerging topics on stimulants and synthetic drugs, including the stimulant and fentanyl overdose mortality epidemic, synthetic stimulants and opioids, psychophysiological phenotyping of reward processing, and promising treatment approaches for Methamphetamine Use Disorder. Following each presentation, presenters answer audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Colluding Crises: Understanding Stimulant and Fentanyl Overdose Mortality
  As fentanyl overdose mortality has climbed precipitously across the United States, rising deaths due to stimulant (cocaine or methamphetamine) toxicity have followed. The interaction between these two crises runs deep and is poorly understood, with a very limited understanding of the causes of death from acute stimulant toxicity, an unclear relationship between stimulant and fentanyl use, and uncertain interactions resulting in overdose death. We will review the trends in overdose death due to stimulants, fentanyl, and the two in combination; the clinical presentation of acute toxicity from stimulants and fentanyl; and existing data elucidating the co-use and toxicity from these drugs. Finally, we will address potential interventions to address the related overdose crisis.
• Psychophysioloigcal phenotyping of reward processing and its modulation with abstinence in cocaine addiction
  The goal of the presentation is to discuss motivational dysregulation, or deficits in reward processing, in substance use disorders and to discuss how these processes change during abstinence. Different aspects of reward processing (e.g., drug-related and non-drug-related) will be defined. Electroencephalography (EEG) technique will be introduced that can be used to objectively assess motivational dysregulation in substance use disorder. To make the case for clinical relevance and significance of this topic, several studies from the presenter's and other research groups on this topic will be presented. The presentation will conclude with a discussion on other brain imaging techniques for studying motivational dysregulation and how such work provides bases for the development of treatments and interventions for substance use disorders.
• Pharmacology of New Synthetic Stimulants and Opioids Appearing in Clandestine Drug Markets
  New psychoactive substances (NPS) are synthetic drugs specifically engineered to bypass current drug control laws. This presentation will provide up-to-date information about the stimulant and opioid NPS that are emerging in clandestine drug markets in the US and elsewhere. The chemical structures, molecular mechanisms of drug action, and preclinical pharmacology for representative stimulant (e.g., eutylone) and opioid (e.g., isotonitazene) NPS will be presented. Clinical symptomatology produced by the drugs will be described. The information provided will be utilized to assess harms, and guide strategies for management and treatment.
• Treatment of Methamphetamine Use Disorder Using Injectable Naltrexone and Oral Bupropion
  Methamphetamine use continues to increase and has now been characterized as the ?fourth wave? of the opioid epidemic. Furthermore, the majority of overdose deaths now involve stimulants. Despite the acknowledgement of this public health crisis, there are no FDA approved treatments for methamphetamine use disorder. This presentation will address this urgency by reviewing outcomes from a recent novel clinical trial which evaluates the efficacy and safety of the combination of extended-release oral bupropion and extended-release injectable naltrexone for the treatment of methamphetamine use disorder.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Federal Agency Session: Special Addresses and Open Discussion

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, on-demand session from the 2022 ASAM State of the Art Course overviews emerging issues and advances in addiction medicine at SAMHSA, NIDA, and NIAAA.
During this 1-hour, on-demand session from the 2022 ASAM State of the Art Course, federal agency leaders from SAMHSA, NIDA, and NIAAA give brief overviews about emerging issues and advances in addiction medicine from their respective organizations. Following the presentations, State of the Art Planning Committee Chair, Dr. Michael I. Fingerhood leads the agencies in a lively discussion about the most pressing topics in addiction medicine.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

New in Neurobiology

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, on-demand session from the 2022 ASAM State of the Art Course identifies new ways to treat, cure, and prevent addiction using advanced neuro-technologies.
Although addiction is widely understood to be a chronic brain disorder, the neurological basis and consequences of addiction remain poorly understood. The presentations in this 1-hour, on-demand session from the 2022 ASAM State of the Art Course identify new ways to treat, cure, and prevent addiction using advanced neuro-technologies. Following each presentation, presenters answer audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Updates on the BRAIN Initiative
  Emerging from formative years, the NIH BRAIN Initiative has matured into a vibrant enterprise spanning a diverse field of researchers from the biological, engineering, and clinical sciences from across the United States and around the world. The rising trajectory of the BRAIN Initiative as a major force in neuroscience discovery presents a timely opportunity to invest in new large-scale projects that offer the potential to transform the field. The BRAIN Initiative is rolling out three transformative projects that will (1) build an atlas of cell types in the human brain, (2) develop a microconnectivity map of an entire mammalian brain, and (3) provide tools for precision access to the identified cell types. Together, these will enable the development of novel interventions for human circuit disorders.
• Brain Mechanisms of Relapse Prevention Medications for Opioid Use Disorder
  Opioid use disorder (OUD) affects multiple neurocognitive domains. Non-invasive neuroimaging techniques, especially functional magnetic resonance imaging (fMRI), have shown great promise in elucidating the neural mechanisms of addiction in general and OUD in particular. The presentation will cover the key domains of OUD-related neurocognitive deficits such as abnormal incentive salience, poor executive control, aberrant emotional reactivity, impaired social cognition, and altered functional connectivity between brain regions. This will be followed by reviewing the fMRI results concerning effects of relapse prevention medications, including agonist and antagonist treatments, on the brain circuits affected by OUD. Lastly, the presentation will discuss the potential of advanced statistical and computational methodologies that may further our mechanistic understanding of OUD and its treatments.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Alcohol Use Disorder: Pharmacotherapy and Recovery

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course examines new research on Alcohol Use Disorder (AUD) treatment, including findings from a cutting-edge alcohol registry, evidence outlining the role of the endocrine system in addiction, and advances in the use of computational modeling and biomarkers to advance personalized medicine for AUD.
Alcohol Use Disorder (AUD) is a heterogeneous disorder characterized by individual variation in clinical features, neurocognitive functioning, molecular pathways, and neural circuits making it challenging to treat. This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course examines new research on AUD treatment, including findings from a cutting-edge alcohol registry, evidence outlining the role of the endocrine system in addiction, and advances in the use of computational modeling and biomarkers to advance personalized medicine for AUD. Following the session, a moderated panel discussion among the presenters answers audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• Facilitating Recovery in the Context of Healthcare: Challenges and Opportunities
  This presentation describes an approach to facilitating recovery across the spectrum of alcohol problems, from unhealthy use through severe alcohol use disorders, in the context of healthcare delivery. We discuss the development, implementation and uses of an innovative, cutting-edge Alcohol Registry, a collaboration between Kaiser Permanente Northern California and the National Institute on Alcohol Abuse and Alcoholism. The data in the Alcohol Registry provides critical diagnostic, alcohol consumption quantity and frequency, demographic and services utilization information for conducting epidemiologic, health services and implementation science research and informs quality improvement efforts across the continuum of care, from primary care to specialty addiction medicine. We discuss systemic challenges to enabling recovery from alcohol problems in healthcare settings, and describe ways to enhance systems? approach to alcohol treatment.
• Gut-Brain Axis and Neuroendocrinology: Translation to Addiction Medicine
  Endocrine signals from the periphery traditionally known to regulate homeostasis, fluid intake, appetite and food intake may play an important role in reward regulation as well as in development of alcohol and substance use disorders, therefore representing promising novel targets in medication development. Dr. Leggio on behalf of his research team and collaborators, will present recent translational preclinical and human data on systems related to the gut-brain axis and to neuroendocrine pathways. Examples include the ghrelin system, the glucagon-like peptide-1 (GLP-1) system and the aldosterone / mineralocorticoid receptor (MR) system. This line of research supports additional efforts aimed to investigate whether these neuroendocrine pathways may represent novel potential targets for medication development for addictions.
• Beyond Treating Acute Alcohol Withdrawal: New Medications to Address Post-Withdrawal Relapse and Recovery
  Despite several approved medications to treat Alcohol Use Disorder (AUD), there are high relapse and treatment failure rates in AUD. Clinical presentation of treatment entering individuals with AUD indicates significant heterogeneity, with severity of illness and varying levels of alcohol withdrawal symptoms and craving impacting treatment course and outcome. Data on effects of moderate to high severity AUD, stress biology and associated poor treatment response will also be shown. Finally, results from a 12-week randomized clinical trial of Prazosin will be presented to show that its efficacy is moderated by alcohol withdrawal symptoms. The findings will be discussed in the context of the need for valid clinical, neural and biological markers to address AUD heterogeneity to improve relapse risk and treatment outcome in AUD.
• Leveraging Systems Pharmacology to Advance Precision Medicine for Treatment of Alcohol Use Disorder
  There is an urgent need to personalize evidence-based treatments for alcohol use disorder (AUD). AUD is a heterogeneous disorder characterized by individual variation in clinical features, neurocognitive functioning, molecular pathways, and neural circuits. Advances will be presented in the use of computational modeling and biomarkers to advance personalized medicine for AUD by predicting likely responders to gabapentin, topiramate and other pharmacological treatments.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Cannabis & Synthetic Cannabinoids

Recorded: Thursday, September 29, 2022 - Saturday, October 1, 2022
On-Demand Session

Overview

This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course outlines some of the interesting findings and topics that have emerged in research on cannabis. Topics will include adolescent cannabis use, oral cannabinoid products, treatment of pain with cannabis, and psychiatric outcomes for patients with Cannabis Use Disorder (CUD).
Cannabis is the most used federally illegal drug in the United States. Over the last several years there has been a steady increase in research on cannabis, and This 1-hour, 45-minute, on-demand session from the 2022 ASAM State of the Art Course outlines some of the interesting findings and topics that have emerged. Topics will include adolescent cannabis use, oral cannabinoid products, treatment of pain with cannabis, and psychiatric outcomes for patients with Cannabis Use Disorder (CUD). Following each presentation, presenters answer audience questions.

This session is comprised of 4 presentations that deep dive into different aspects of the overall topic.

• A Different Perspective on Adolescent Cannabis Use
  This presentation reframes the issue of adolescent cannabis use from a risk behavior to a reflection of trauma and adversity. First, the presenter will discuss the epidemiology of adolescent cannabis use, noting that the majority of early initiators and daily users have experienced substantial adversity. Next, she will summarize a mismatch between school-based prevention programs and determinants of use. The central argument is that approaches for preventing adolescent cannabis use should involve ensuring that young people have the resources to thrive.
• Using Human Laboratory Methods to Understand the Pharmacokinetics and Pharmacodynamics of Oral Cannabinoid Products
  This talk will summarize results from human laboratory studies on cannabis edibles. Topics include differences in the effects of cannabis edibles and other routes of cannabis administration (e.g., smoked vs vaped), product and user factors that influence edible effects, drug-drug interactions between oral THC/CBD and common medications, interactive effects between THC and CBD when orally administered, and measuring impairment from cannabis edibles. Clinical and regulatory implications will be discussed and an overview of clinical laboratory methods will be given.
• Cannabis and the Pain Dilemma
  A concise review of the research on treating pain using different forms of cannabis, including practical approaches to patients who use a variety of products for this indication. Note that this session does not include an endorsement of any particular cannabis formulations or products for the treatment of pain, but rather discusses the current state of evidence and how it can inform clinical work. Participants will also receive a list of further reading/resources to expand their understanding of the concepts presented.
• Psychiatric Outcomes in Individuals with Cannabis Use Disorder
  This session will review research on psychiatric outcomes related to cannabis use. The focus of the presentation will be negative affect states (e.g. depression, anxiety, suicidal ideation) associated with regular cannabis use, and changes in symptoms of negative affect associated with cannabis use reduction or abstinence. Clinical implications in the management of cannabis use disorder will be discussed, including off-label medications that have been studied for the treatment of cannabis use disorder and that may impact negative affect states.

These sessions are intended for experienced learners and are taught an intermediate or advanced level. The target audience includes:

• Addiction medicine specialists who are interested in the latest research in the field and its translation to clinical practice
• Physicians and other healthcare professionals who treat patients with addiction and seek an advanced level of knowledge
• Scientists, researchers, public health officials and advocates dedicated to the field of addiction medicine

This conference addresses all 6 ACGME Competencies.

Learning Objectives

At the end of the course, learners should be able to:

1. Discuss the important, new, scientific breakthroughs in the prevention, diagnosis, and treatment of addiction.
2. Critically evaluate new science and describe how it changes the current understanding of addiction and co-occurring medical or psychiatric disorders.
3. Develop practical applications for integrating new and emerging science into practice.
4. Identify gaps in the field of addiction medicine that future research can address.
5. Create a network of colleagues and resources to support the learner's practice or form future research collaborations.

Registration Rates

*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM eLearning Center refund requests must be made in writing to Education@ASAM.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or eLearning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 10/1/2025

Instructions

1. Click on the Contents tab to begin this activity.
2. Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

CME, CE, CEU and Other Credit Types

ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
The American Society of Addiction Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) / Continuing Certification Program (CCP)

The ASAM State of the Art Course  meets the CME requirements for the following primary boards:
• American Board of Medical Specialties (ABMS)
• American Board of Preventive Medicine (ABPM)
• American Board of Anesthesiology (ABA)
• American Board of Pediatrics (ABP)
• American Board of Internal Medicine (ABIM)
• American Board of Surgery (ABS)
• American Board of Psychiatry and Neurology (ABPN)
• American Board of Addiction Medicine (ABAM)
• Royal College of Physicians and Surgeons of Canada (RCPSC

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.